SEC Form 3 · accession 0001209191-15-042836
ReShape Lifesciences Inc. · RSLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bradford C Hancock
Officer — Chief Commercial Officer
Period of report
May 6, 2015
Accepted (ET)
May 14, 2015 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001371217
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.40 | holding | — | — | — | Nov 17, 2015 | Dec 11, 2024 | Common Stock | 400,000 | — | D |
| Stock Option (right to buy)F2 | $1.11 | holding | — | — | — | Apr 9, 2015 | Mar 9, 2025 | Common Stock | 80,000 | — | D |
Explanation of responses
- F1Vests as to 25% on date noted and thereafter in cumulative installments of 1/36th per month.
- F2Vests in increments of 1/48th per month, beginning the date shown.
Remarks
EX 24: POWER OF ATTORNEY DATED MAY 11, 2015 ATTACHED.